MindMaze

MindMaze is a global leader in digital neuro-therapeutics (DTx) solutions, dedicated to accelerating the brain's ability to recover, learn, and adapt. With over a decade of pioneering work at the intersection of neuroscience, bio-sensing, engineering, mixed reality, and artificial intelligence, MindMaze is transforming healthcare. The company's healthcare division is tackling some of the most challenging problems in neurology, including stroke, Alzheimer's disease, and Parkinson's disease, by creating a universal platform for brain health and recovery, alongside unique digital therapeutic interventions.

MindMaze's commitment to innovation is evident in its FDA-cleared and CE-marked neuro-digital therapeutics, which significantly accelerate patients' recovery from critical neurological conditions. The company's primary address is Chemin de Roseneck 5, Lausanne, 1006, CH. MindMaze continues to expand its reach and impact, solidifying its position as a key player in the biotechnology research and neuro-therapeutics landscape.

MindMaze is at the forefront of technological advancement, driving progress and improving patient outcomes worldwide. The company’s forward-thinking approach ensures it remains a leader in the field. We invite MindMaze's management team to create a customized and exclusive company showcase and product listing on our platform to further highlight their groundbreaking work.